By Plenary Sessions: Katrin Kuusemäe

The issue arose concerning the necessity of establishing a Riigikogu (Parliamentary) investigative committee to assess the risks associated with COVID-19 mRNA vaccines, a proposal which the Constitutional Committee clearly opposed (with 6 votes cast in favor of rejection). His/Her role as rapporteur suggests support for the committee majority's decision, which favors relying on existing supervisory bodies (the Estonian Agency of Medicines). The position is primarily procedural and institutionally based, emphasizing the adequacy of the existing regulatory framework.